KR100856938B1 - 불포화 고급지방산의 페길화 방법 - Google Patents
불포화 고급지방산의 페길화 방법 Download PDFInfo
- Publication number
- KR100856938B1 KR100856938B1 KR1020060039032A KR20060039032A KR100856938B1 KR 100856938 B1 KR100856938 B1 KR 100856938B1 KR 1020060039032 A KR1020060039032 A KR 1020060039032A KR 20060039032 A KR20060039032 A KR 20060039032A KR 100856938 B1 KR100856938 B1 KR 100856938B1
- Authority
- KR
- South Korea
- Prior art keywords
- fatty acids
- higher fatty
- pegylated
- unsaturated
- cla
- Prior art date
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
- A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
- C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
- C08G65/32—Polymers modified by chemical after-treatment
- C08G65/329—Polymers modified by chemical after-treatment with organic compounds
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
Claims (2)
- 탄소 수가 16개 내지 22개인 불포화 고급지방산과 폴리에틸렌글리콜을 60℃ 내지 200℃에서 30분 내지 10시간 동안 교반하면서 반응시키는 것을 특징으로 하는 불포화 고급지방산의 페길화 방법.
- 삭제
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020060039032A KR100856938B1 (ko) | 2006-04-28 | 2006-04-28 | 불포화 고급지방산의 페길화 방법 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020060039032A KR100856938B1 (ko) | 2006-04-28 | 2006-04-28 | 불포화 고급지방산의 페길화 방법 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20070106315A KR20070106315A (ko) | 2007-11-01 |
KR100856938B1 true KR100856938B1 (ko) | 2008-09-05 |
Family
ID=39062322
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020060039032A KR100856938B1 (ko) | 2006-04-28 | 2006-04-28 | 불포화 고급지방산의 페길화 방법 |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR100856938B1 (ko) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100905084B1 (ko) * | 2007-07-06 | 2009-06-30 | 재단법인서울대학교산학협력재단 | 항암용 불포화 고급지방산 유도체 및 그 제조 방법 |
KR102175655B1 (ko) * | 2019-04-03 | 2020-11-06 | 연세대학교 원주산학협력단 | 페길레이션된 아이코사펜타엔산 유도체, 이의 제조 방법 및 이를 포함하는 피부 노화 방지용 조성물 |
CN116178699A (zh) * | 2022-09-09 | 2023-05-30 | 浙江大学医学院附属第一医院 | 一种可促进药物入胞的药物递送载体材料及其制备方法和应用 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR940018091A (ko) * | 1993-01-27 | 1994-08-16 | 까뜨리오나 프란세스 마르 | 불포화 지방산을 포함하는 처방 |
KR20060022668A (ko) * | 2003-05-28 | 2006-03-10 | 에자이 가부시키가이샤 | 고급지방산 유도체 함유 조성물 및 음식물 |
-
2006
- 2006-04-28 KR KR1020060039032A patent/KR100856938B1/ko active IP Right Grant
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR940018091A (ko) * | 1993-01-27 | 1994-08-16 | 까뜨리오나 프란세스 마르 | 불포화 지방산을 포함하는 처방 |
KR20060022668A (ko) * | 2003-05-28 | 2006-03-10 | 에자이 가부시키가이샤 | 고급지방산 유도체 함유 조성물 및 음식물 |
Also Published As
Publication number | Publication date |
---|---|
KR20070106315A (ko) | 2007-11-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Aldayel et al. | Lipid nanoparticles with minimum burst release of TNF-α siRNA show strong activity against rheumatoid arthritis unresponsive to methotrexate | |
Wang et al. | Self‐assembling prodrugs by precise programming of molecular structures that contribute distinct stability, pharmacokinetics, and antitumor efficacy | |
Ding et al. | The performance of thiol-terminated PEG-paclitaxel-conjugated gold nanoparticles | |
Zhao et al. | Chondroitin sulfate-based nanocarriers for drug/gene delivery | |
Klyachko et al. | Cross-linked antioxidant nanozymes for improved delivery to CNS | |
Yang et al. | A thermoresponsive biodegradable polymer with intrinsic antioxidant properties | |
Kumar et al. | Ketoconazole encapsulated in chitosan-gellan gum nanocomplexes exhibits prolonged antifungal activity | |
Howard et al. | Polymer micelles with hydrazone-ester dual linkers for tunable release of dexamethasone | |
Nosrati et al. | Bovine serum albumin: an efficient biomacromolecule nanocarrier for improving the therapeutic efficacy of chrysin | |
Guo et al. | Synergistic anti-tumor activity of paclitaxel-incorporated conjugated linoleic acid-coupled poloxamer thermosensitive hydrogel in vitro and in vivo | |
Huang et al. | Amphiphilic prodrug-decorated graphene oxide as a multi-functional drug delivery system for efficient cancer therapy | |
Wang et al. | Hydroxyethyl starch based smart nanomedicine | |
Bhatnagar et al. | Hyaluronic acid grafted PLGA copolymer nanoparticles enhance the targeted delivery of Bromelain in Ehrlich’s Ascites Carcinoma | |
CN110623925B (zh) | 一种雷帕霉素纳米缓释剂及其制备方法 | |
Somu et al. | Supramolecular nanoassembly of lysozyme and α-lactalbumin (apo α-LA) exhibits selective cytotoxicity and enhanced bioavailability of curcumin to cancer cells | |
KR100856938B1 (ko) | 불포화 고급지방산의 페길화 방법 | |
Chen et al. | ROS-scavenging biomaterials for periodontitis | |
Sun et al. | Construction and characterization of curcumin nanoparticles system | |
Hao et al. | Reactive oxygen species-responsive polypeptide drug delivery system targeted activated hepatic stellate cells to ameliorate liver fibrosis | |
Yang et al. | Advances in delivering oxidative modulators for disease therapy | |
Kong et al. | Intracellular pH-responsive iron-catechin nanoparticles with osteogenic/anti-adipogenic and immunomodulatory effects for efficient bone repair | |
Cui et al. | Engineering milk-derived exosome for enhancing cellular astaxanthin delivery | |
WO2021084166A1 (fr) | Nanostructure d'or comprenant des enzymes et des agents antioxydants | |
Yeo et al. | Polymeric antioxidant materials for treatment of inflammatory disorders | |
Li et al. | Construction of glycogen-based nanoparticles loaded with resveratrol for the alleviation of high-fat diet-induced nonalcoholic fatty liver disease |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20120824 Year of fee payment: 5 |
|
FPAY | Annual fee payment |
Payment date: 20130816 Year of fee payment: 6 |
|
FPAY | Annual fee payment |
Payment date: 20140722 Year of fee payment: 7 |
|
FPAY | Annual fee payment |
Payment date: 20150730 Year of fee payment: 8 |
|
FPAY | Annual fee payment |
Payment date: 20160825 Year of fee payment: 9 |
|
FPAY | Annual fee payment |
Payment date: 20170829 Year of fee payment: 10 |
|
FPAY | Annual fee payment |
Payment date: 20180828 Year of fee payment: 11 |
|
FPAY | Annual fee payment |
Payment date: 20190703 Year of fee payment: 12 |